Introduction
The First International Consultation on Erectile Dysfunction in Paris July 1999 have defined erectile dysfunction (ED) as the consistent or recurrent inability to attain and/or maintain penile erection sufficient for sexual performance for a 3-month period. 1 The prevalence of complete ED in healthy men triples from 5% at 40 y to 15% at their 70s. 2 The incidence of ED is about 26 cases per 1000 men annually, and increases with age, lower education, diabetes, heart diseases, and hypertension. 3 Commonly, patients are divided into two groups: psychogenic and organic. The ratio of organic-topsychogenic male sexual dysfunction has been reported to be directly proportional to age; with 70% of men under 35 y of age having psychogenic ED and 85% of men over 50 y of age having organic ED. 4 It is well known that ED is seen in patients with manifest arteriosclerotic disease and may be a symptom of a systemic vascular problem related to well-known risk factors such as smoking, hypertension, hyperlipidemia, and DM. 5 A marked increase of LDL and a decrease of HDL fractions have been reported in patients with vasculogenic impotence as compared to those with nonvasculogenic ED. 6 In the present study, we have compared the plasma lipid profile of patients suffering from organic ED with a control group.
Materials and methods
A total of 100 patients aged 43.59710.51 y (range: 20-60 y) suffering from organic ED as evidenced by International Index of Erectile Function questionnaire (IIEF-5), over January 2000 to June 2003 participated in this study at Sina Hospital.
Intracavernous injection (using 40 mg papaverin) and nocturnal penile tumescence monitoring by a UroHealth Systems Rigi-Scan (optional) was used to exclude patients with psychogenic (nonorganic) ED.
The exclusion criteria were: diabetes mellitus, hypertension (BP4140/90 mmHg), renal failure, hypogonadysm, Peyronie disease, BMI428 kg/m 2 , pelvic or spinal cord injury, history of vascular surgery, multiple sclerosis, thyroid dysfunction, cardiac diseases, drugs/narcotics use or smoking.
For comparison, 100 healthy individuals, aged 43.7279.76 y (range: 20-60 y) with no evidence of ED according to history and, matched with the case group in age and without the exclusion criteria, enrolled in our study.
All the patients and controls were examined physically and assessed with the IIEF-5. Mild, moderate and severe ED were defined as the scores of 18-24, 11-17, and less than 10. Scores between 25 and 30 were considered potent (control group). Physical examination consisted of penile palpation for Peyronie's disease, assessment of penile and perianal sensation, anal sphincter tone and response of the bulbocavernous reflex.
Fasting plasma lipid profile (cholesterol, triglyceride (TG), HDL, LDL) have been measured in cases and controls with the same kits and laboratory technique (enzymatic spectrophotometery).
The optimum level and normal upper limit were considered 200 and 240 mg/dl for cholestrol, and 130 and 160 mg/dl for LDL. Some extra laboratory tests (BUN, Cr, FBS, morning testosterone, LH, prolactin, TSH, T4) were used to find the individuals with exclusion criteria, if justified according to history.
The SPSS (9.00) was used for statistical analysis. The t-tests were used for comparisons. A P-value less than 0.05 was considered statistically significant.
Results
Mild, moderate, and severe ED were observed in 2, 41, and 57 patients. Delay in seeking treatment was less than 1 y in 48 patients, 1-2 y in 27 patients and more than 3 y in 35 patients. In order to find out the influence of age we divided the individuals into two groups: o40 and Z40 y.
Mean plasma cholesterol level in case and control groups were 235.58776.56 and 209.15747.63, which was statistically significant (P ¼ 0.004). In those patients Z40 y of age this relation for cholesterol and LDL was also significant (P ¼ 0.02 and 0.004, respectively). However, in the patients o40 y the difference was not significant. The plasma cholesterol level for age groups is shown in Table 1 . As depicted in Table 1 , 48% of the patients and 17% of the controls had high plasma cholesterol level (P ¼ 0.02). Such significant differences was also found in individuals Z40 y old (55.9 and 24.2% respectively, P ¼ 0.03), but not in o40 y.
Mean plasma LDL level in patients and control group were 163.68775 and 136.79742.16 (P ¼ 0.002). In the patients o40 y, we did not find such significant differences. However, in the patients Z40 y old the difference was significant (P ¼ 0.004).
The serum LDL levels by age groups are shown in Table 2 . In all, 53% of patients and 17% of the controls had high plasma LDL (P ¼ 0.02). Similar findings were found in individuals Z40 y old (61.8, 21%, respectively, P ¼ 0.04). Nevertheless, the difference was not significant for individuals o40 y.
Mean observed TG in patients and control groups were 257.53753.80 and 251.287100 (P ¼ 0.58), which was not affected by age.
Mean plasma HDL level in patients and control group were 39.82722.01 and 42.42711.62, not statistically significant (P ¼ 0.29) and not influenced by age.
Applying the linear-regression test, the coefficient for cholesterol reduced the IIEF-5 score by À0.036, which means if the other parameters remained constant, then to every mg/dl increase in cholesterol, we have to subtract 0.036 from the patient's score. Likewise, the coefficient for LDL was À0.035. This negative correlations were quite descent. R 2 for LDL and cholesterol was calculated separately (each around 0.04) that means cholesterol (or LDL) only contributes 4% to the etiologies for ED. 
Discussion
The association between hyperlipidemia and ED was originally attributed to atherosclerosis in the hypogastric-cavernosal arterial bed, with a subsequent deficiency in penile arterial inflow. 7 More recently, the importance of cavernosal relaxation in the erectile process has become apparent. Impairment of endothelium-dependent relaxation in numerous vascular beds in men with hypercholesterolemia has been clearly evidenced. [8] [9] [10] These impairments have also been shown to be reversible using lipid-lowering therapies. 11 In Saltzman et al 12 observational study, they noted that erectile function could be improved by atorvastatin in men with hypercholesterolemia when it was the only risk factor for ED. In animal models of hypercholesterolemia, studies show both deficient endothelium-and neurogenic-dependent cavernosal relaxations. 13, 14 These changes were also reversible by normalizing serum cholesterol levels through dietary reduction. Ultrastructural assessments in these studies showed atherosclerotic-like processes in focal areas of the cavernosal sinusoids.
14 These changes were not thought to be the primary cause of ED, but more likely the precursors to the later, more complex atherosclerotic lesions.
Although ED is frequently seen in patients with manifestations of arteriosclerosis disease, the independent contribution of serum lipid profile in predicting ED is unclear. In the study conducted by Wei et al 15 every mmol/liter increase in total cholesterol was associated with 1.32 times the risk of ED (95% CI, 1.04-1.68), while every mmol/liter increase in HDL cholesterol was associated with 0.38 times the risk (95% CI, 0.18-0.80). Men with an HDL cholesterol measurement over 1.55 mmol/liter (60 mg/dl) had 0.30 times the risk (95% CI, 0.09-1.03) as did men with less than 0.78 mmol/liter (30 mg/dl). Men with total cholesterol over 6.21 mmol/liter (240 mg/dl) had 1.83 times the risk (95% CI 1.00-3.37) as did men with less than 4.65 mmol/liter (180 mg/dl). Thus, the authors conclude that a high level of total cholesterol and a low level of HDL cholesterol are important risk factors for ED. Manning et al 16 found a correlation between high LDL and organic ED (68.6 vs 32.4% in the psychogenic impotence group) and a clear positive correlation between high LDL and caverno-venous insufficiency was determined. In the study conducted by Kim, 17 the incidence of abnormally high level of LDL was significantly higher in the patients than in the control men, but there was no significant difference in the incidence of abnormally high blood level of total cholesterol or TG and abnormally low blood level of HDL between the two groups. In Atahan et al 18 study, lipoprotein A and total cholestrol levels were higher in both peripheral and cavernosal samples of vasculogenic ED group than in nonvasculogenic ED group, with no differences between peripheral and cavernosal blood levels within the same groups. There were no significant changes in TG and HDL levels in either group.
Interestingly, Walczak et al, 19 studying the risk factors of ED, emphasized the fact that 90% of these are also risk factors for CAD. They concluded that impotence is an important symptom, and its presence should instigate assessment and aggressive management of coexistent risk factors for CAD. Intervention could restore sexual function and ultimately improve cardiovascular health. SanchezCruz et al 20 assessed the health-related quality-oflife factors associated with ED. The prevalence of ED based on IIEF was 18.9%. OR was calculated for diabetes, 4 hypertension (1.58), high cholesterol (1.63), peripheral vascular disease (2.37) and allergy (3.08). In the study of Feldman et al 21 after adjustment for age, a higher probability of impotence was directly correlated with heart disease, high cholesterol level was an independent predictor of impotence. ED was strongly correlated with age in all seven domains of sexual function. High TG levels, blood pressure medication, and noncancer surgery for prostate disease were independent predictors of poor sexual function at older ages. High cholesterol level was an independent predictor of impotence. They concluded that cardiovascular risk factors were predictors of ED in these older men, suggesting that prevention may benefit sexual function. Our finding suggest that there is a significant correlation between total cholesterol and LDL with ED probably indicating an etiologic role for these lipids in organic ED. Every mg/dl increase in plasma cholesterol and LDL level decrease IIEF-5 scores 0.036 and 0.035, respectively, according to our study. We have shown this correlation was not significant in men o40 y, thus confirming the theory that organic factors play their role especially in the elderly. We should notice that the damage from atherosclerosis takes time and one would expect that older men would show more pathology.
Conclusion
ED is a symptom and not a disease. We can almost always find a factor that causes ED. While visiting an ED patient, holistic management should not be neglected because etiologic factors of ED can also affect the whole body of these patients.
We recommend that men's lipid profile be tested regularly, especially in aged individuals. The individuals at risk for hyperlipidemia are also at increased risk for both ED and other complications of hyperlipidemia. They can prevent these complications by modifying their lifestyle like increasing body activity and changing diet.
